Coherus BioSciences Inc (NAS:CHRS)
$ 1.78 0.02 (1.14%) Market Cap: 204.21 Mil Enterprise Value: 423.31 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 42/100

Coherus BioSciences Inc at Bank of America Global Research Healthcare Conference (Virtual) Transcript

May 12, 2021 / 05:15PM GMT
Release Date Price: $13.85 (-1.67%)
Jason Matthew Gerberry
BofA Securities, Research Division - MD in US Equity Research

Good day, everybody. Thanks for joining us to the Bank of America Annual Health Care Conference. My name is Jason Gerberry. I'm one of the biopharma analysts at BofA, and I'm pleased to be introducing our next company presenter, Coherus and CEO, Denny Lanfear. So Denny, first off, thanks for joining us today.

Dennis M. Lanfear
Coherus BioSciences, Inc. - Chairman, President & CEO

Nice to see you guys again. Thanks for the invitation. Sorry for the technical.

Questions & Answers

Jason Matthew Gerberry
BofA Securities, Research Division - MD in US Equity Research

Yes. No, it's only a few minutes delayed, but hopefully, we can send all our questions in. So maybe the first question I want to ask you is more -- how do you think the market should think about your strategy going forward in lieu of the in-license of toripalimab anti-PD-1 brand? And do you feel like it's a fundamental pivot in the company strategy to have a

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot